Enhancing the effectiveness of nucleoside analogs with mTORC1 blockers to treat acute myeloid leukemia patients

Παρόμοια τεκμήρια

• A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia
  ανά: Chiarini, Francesca, κ.ά.
  Έκδοση: (2012)
• The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: Implications for therapy of drug resistant breast cancers
  ανά: Cappellini, Alessandra, κ.ά.
  Έκδοση: (2009)
• Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
  ανά: Camilla Evangelisti, κ.ά.
  Έκδοση: (2018-06-01)
• Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
  ανά: Evangelisti, Camilla, κ.ά.
  Έκδοση: (2018)
• The Unfolded Protein Response: A Novel Therapeutic Target in Acute Leukemias
  ανά: Alberto M. Martelli, κ.ά.
  Έκδοση: (2020-02-01)